Etiket: Cosentyx
Novartis Stock: Novartis presents positive long-term data for Cosentyx
The pharmaceutical company Novartis has presented long-term data on the drug Cosentyx (secukinumab) in use against the skin disease hidradenitis suppurativa (HS). ttn-28